Ind-Swift Ltd

Ind-Swift Ltd

₹ 24.8 -1.97%
02 May - close price
About

Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products

Key Points

Business Overview:[1]
Company has expertise in finished goods dosage, Active Pharmaceutical Ingredients (API’s) and herbal products. Company also diversified into multiple fields viz., Infrastructure, Printing, Packaging & Stationary, Education, and Media Publication with its every unit as an independent profit earning center

  • Market Cap 134 Cr.
  • Current Price 24.8
  • High / Low 31.2 / 7.65
  • Stock P/E
  • Book Value -132
  • Dividend Yield 0.00 %
  • ROCE 8.28 %
  • ROE %
  • Face Value 2.00

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoters have pledged 42.8% of their holding.
  • Earnings include an other income of Rs.78.3 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
90 97 104 106 95 104 107 106 149 116 103
80 85 92 96 90 93 89 98 130 105 98
Operating Profit 11 13 12 10 5 11 18 8 18 11 4
OPM % 12% 13% 12% 9% 5% 11% 17% 8% 12% 10% 4%
7 6 3 7 2 1 3 67 6 3 3
Interest 13 16 14 14 15 15 15 14 15 18 15
Depreciation 8 8 8 8 7 7 7 7 7 7 7
Profit before tax -3 -5 -7 -5 -15 -11 -1 53 2 -11 -15
Tax % -13% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
-4 -5 -7 -5 -15 -11 -1 53 2 -11 -15
EPS in Rs -0.66 -0.91 -1.25 -1.01 -2.85 -1.96 -0.19 9.80 0.44 -1.98 -2.76
Raw PDF
Upcoming result date: 14 May 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2022 Mar 2023 TTM
308 263 270 398 411 473
465 328 262 352 369 431
Operating Profit -157 -65 8 45 42 42
OPM % -51% -25% 3% 11% 10% 9%
13 -246 -20 24 72 78
Interest 19 16 7 57 60 63
Depreciation 36 36 35 32 29 27
Profit before tax -200 -363 -53 -20 26 30
Tax % -0% -0% -1% -2% 0%
-214 -373 -50 -20 26 30
EPS in Rs -42.42 -68.81 -9.31 -3.70 4.81 5.50
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 9%
3 Years: %
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: -18%
3 Years: %
TTM: 5%
Stock Price CAGR
10 Years: 14%
5 Years: 38%
3 Years: 81%
1 Year: 194%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2022 Mar 2023 Sep 2023
Equity Capital 10 11 11 11 11 11
Reserves -270 -641 -688 -731 -716 -724
Preference Capital 14 14 14 14 14
1,047 1,048 1,041 1,021 978 976
268 246 251 331 376 376
Total Liabilities 1,055 665 615 632 649 639
374 342 311 236 216 205
CWIP 4 2 0 9 30 35
Investments 39 39 46 64 54 54
638 281 258 323 349 346
Total Assets 1,055 665 615 632 649 639

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2022 Mar 2023
-119 -2 7 50 73
10 4 -6 -18 -29
110 -11 -6 -45 -47
Net Cash Flow 0 -8 -5 -13 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2022 Mar 2023
Debtor Days 451 151 113 83 93
Inventory Days 151 86 108 120 150
Days Payable 290 356 394 353 393
Cash Conversion Cycle 311 -119 -173 -149 -150
Working Capital Days 409 -37 -57 -69 -77
ROCE % -14% -4% 8%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.55% 55.55% 55.55% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58%
1.77% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
42.68% 44.44% 44.44% 44.42% 44.42% 44.42% 44.40% 44.42% 44.42% 44.42% 44.42% 44.42%
No. of Shareholders 11,86912,42413,59614,00914,29614,42214,92714,78514,59013,74514,21916,438

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents